{
    "xml": "<topic id=\"PHP2918\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/oxcarbazepine\" basename=\"oxcarbazepine\" title=\"OXCARBAZEPINE\">\n<title>OXCARBAZEPINE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_900\" namespace=\"/interactions/list-of-drug-interactions/antiepileptics/oxcarbazepine\">Oxcarbazepine</xref>\n</p>\n<data name=\"vtmid\">116511002</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_926692410\" title=\"Antiepileptics\">Antiepileptics</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP67808\" outputclass=\"indicationsAndDose\" rev=\"1.36\" parent=\"/drugs/oxcarbazepine\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Monotherapy for the treatment of focal seizures with or without secondary generalised tonic-clonic seizures</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 6&#8211;17 years</p>\n<p>Initially 4&#8211;5&#8239;mg/kg twice daily (max. per dose 300&#8239;mg), then increased in steps of up to 5&#8239;mg/kg twice daily, adjusted according to response, dose to be adjusted at weekly intervals; maximum 46&#8239;mg/kg per day.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 300&#8239;mg twice daily, then increased in steps of up to 600&#8239;mg daily, adjusted according to response, dose to be adjusted at weekly intervals; usual dose 0.6&#8211;2.4&#8239;g daily in divided doses.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Adjunctive therapy for the treatment of focal seizures with or without secondary generalised tonic-clonic seizures</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 6&#8211;17 years</p>\n<p>Initially 4&#8211;5&#8239;mg/kg twice daily (max. per dose 300&#8239;mg), then increased in steps of up to 5&#8239;mg/kg twice daily, adjusted according to response, dose to be adjusted at weekly intervals; maintenance 15&#8239;mg/kg twice daily; maximum 46&#8239;mg/kg per day.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 300&#8239;mg twice daily, then increased in steps of up to 600&#8239;mg daily, adjusted according to response, dose to be adjusted at weekly intervals; usual dose 0.6&#8211;2.4&#8239;g daily in divided doses.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of primary generalised tonic-clonic seizures</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 300&#8239;mg twice daily, then increased in steps of up to 600&#8239;mg daily, adjusted according to response, dose to be increased at weekly intervals; usual dose 0.6&#8211;2.4&#8239;g daily in divided doses.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseAdjustments\">\n<title>Dose adjustments due to interactions</title>\n<sectiondiv>\n<p>In adjunctive therapy, the dose of concomitant antiepileptics may need to be reduced when using high doses of oxcarbazepine.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64550\" outputclass=\"unlicensedUse\" rev=\"1.21\" parent=\"/drugs/oxcarbazepine\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>Not licensed for the treatment of primary generalised tonic-clonic seizures.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP54700\" outputclass=\"cautions\" rev=\"1.29\" parent=\"/drugs/oxcarbazepine\">\n<title>Cautions</title>\n<body>\r\n<section outputclass=\"cautions\">\r\n<p>\r\n<ph outputclass=\"caution\">Avoid in <xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>\r\n</ph>; <ph outputclass=\"caution\">cardiac conduction disorders</ph>; <ph outputclass=\"caution\">heart failure</ph>; <ph outputclass=\"caution\">hyponatraemia</ph>\r\n</p>\r\n </section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP67600\" outputclass=\"interactions\" rev=\"1.11\" parent=\"/drugs/oxcarbazepine\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (oxcarbazepine).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP66548\" outputclass=\"sideEffects\" rev=\"1.15\" parent=\"/drugs/oxcarbazepine\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal pain</ph>; <ph outputclass=\"sideEffect\">acne</ph>; <ph outputclass=\"sideEffect\">agitation</ph>; <ph outputclass=\"sideEffect\">alopecia</ph>; <ph outputclass=\"sideEffect\">amnesia</ph>; <ph outputclass=\"sideEffect\">asthenia</ph>; <ph outputclass=\"sideEffect\">ataxia</ph>; <ph outputclass=\"sideEffect\">confusion</ph>; <ph outputclass=\"sideEffect\">constipation</ph>; <ph outputclass=\"sideEffect\">depression</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">diplopia</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">drowsiness</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">hyponatraemia</ph>; <ph outputclass=\"sideEffect\">impaired concentration</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">nystagmus</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">tremor</ph>; <ph outputclass=\"sideEffect\">visual disorders</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Leucopenia</ph>; <ph outputclass=\"sideEffect\">urticaria</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Arrhythmias</ph>; <ph outputclass=\"sideEffect\">atrioventricular block</ph>; <ph outputclass=\"sideEffect\">hepatitis</ph>; <ph outputclass=\"sideEffect\">multi-organ hypersensitivity disorders</ph>; <ph outputclass=\"sideEffect\">pancreatitis</ph>; <ph outputclass=\"sideEffect\">Stevens-Johnson syndrome</ph>; <ph outputclass=\"sideEffect\">systemic lupus erythematosus</ph>; <ph outputclass=\"sideEffect\">thrombocytopenia</ph>; <ph outputclass=\"sideEffect\">toxic epidermal necrolysis</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Aplastic anaemia</ph>; <ph outputclass=\"sideEffect\">bone marrow depression</ph>; <ph outputclass=\"sideEffect\">hypertension</ph>; <ph outputclass=\"sideEffect\">hypothyroidism</ph>; <ph outputclass=\"sideEffect\">neutropenia</ph>; <ph outputclass=\"sideEffect\">osteoporotic bone disorders</ph>; <ph outputclass=\"sideEffect\">pancytopenia</ph>; <ph outputclass=\"sideEffect\">suicidal ideation</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP55004\" outputclass=\"allergyAndCrossSensitivity\" rev=\"1.28\" parent=\"/drugs/oxcarbazepine\">\n<title>Allergy and cross-sensitivity</title>\n<body>\r\n\r\n<section outputclass=\"allergyAndCrossSensitivityCrossSensitivity\">\r\n<sectiondiv>\r\n<p>Caution in patients with hypersensitivity to carbamazepine.</p>\r\n<p>Antiepileptic hypersensitivity syndrome associated with oxcarbazepine. See under <xref format=\"dita\" href=\"#PHP78230\" type=\"bookmark\" namespace=\"/treatment-summaries/epilepsy\">Epilepsy</xref> for more information.</p>\n</sectiondiv>\n</section>\r\n</body>\n</topic>\n<topic id=\"PHP54873\" outputclass=\"breastFeeding\" parent=\"/drugs/oxcarbazepine\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Amount probably too small to be harmful but manufacturer advises avoid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67866\" outputclass=\"hepaticImpairment\" parent=\"/drugs/oxcarbazepine\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Caution in severe impairment&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67052\" outputclass=\"renalImpairment\" parent=\"/drugs/oxcarbazepine\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>Halve initial dose if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>; increase according to response at intervals of at least 1 week.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Halve initial dose if estimated glomerular filtration rate less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, increase according to response at intervals of at least 1 week.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP66797\" outputclass=\"preTreatmentScreening\" rev=\"1.6\" parent=\"/drugs/oxcarbazepine\">\n<title>Pre-treatment screening</title>\n<body>\n<section>\n<sectiondiv>\n<p>Test for HLA-B*1502 allele in individuals of Han Chinese or Thai origin (avoid unless no alternative&#8212;risk of Stevens-Johnson syndrome in presence of HLA-B*1502 allele).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP64445\" outputclass=\"monitoringRequirements\" parent=\"/drugs/oxcarbazepine\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Monitor plasma-sodium concentration in patients at risk of hyponatraemia.</p>\n<p>Monitor body-weight in patients with heart failure.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57663\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.11\" parent=\"/drugs/oxcarbazepine\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Patients may need to be maintained on a specific manufacturer&#8217;s branded or generic oxcarbazepine product.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Switching between formulations</p>\n<p>Care should be taken when switching between oral formulations. The need for continued supply of a particular manufacturer's product should be based on clinical judgement and consultation with the patient or their carer, taking into account factors such as seizure frequency and treatment history.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP67239\" outputclass=\"patientAndCarerAdvice\" rev=\"1.17\" parent=\"/drugs/oxcarbazepine\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children: Oxcarbazepine for preventing seizures</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/oxcarbazepine-for-preventing-seizures\">www.medicinesforchildren.org.uk/oxcarbazepine-for-preventing-seizures</xref>\n</p>\n</sectiondiv>\n</section>\r\n<section outputclass=\"generalPatientAdvice\">\r\n<sectiondiv>\r\n<p outputclass=\"title\">Blood, hepatic, or skin disorders</p>\r\n<p>Patients or their carers should be told how to recognise signs of blood, liver, or skin disorders, and advised to seek immediate medical attention if symptoms such as lethargy, confusion, muscular twitching, fever, rash, blistering, mouth ulcers, bruising, or bleeding develop.</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP2918-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/oxcarbazepine\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral suspension</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76480\" title=\"Tablet\" namespace=\"/drugs/oxcarbazepine/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76506\" title=\"Oral suspension\" namespace=\"/drugs/oxcarbazepine/oral-suspension\">Oral suspension</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78143\" namespace=\"/treatment-summaries/contraceptives-interactions\" title=\"Contraceptives, interactions\" count=\"1\" rel=\"backlink\">Contraceptives, interactions</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_900\" namespace=\"/interactions/list-of-drug-interactions/antiepileptics/oxcarbazepine\" title=\"Oxcarbazepine\" count=\"1\" rel=\"link\">Oxcarbazepine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78608\" namespace=\"/treatment-summaries/acute-porphyrias\" title=\"Acute porphyrias\" count=\"1\" rel=\"link\">Acute porphyrias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78230\" namespace=\"/treatment-summaries/epilepsy\" title=\"Epilepsy\" count=\"1\" rel=\"link\">Epilepsy</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76480\" namespace=\"/drugs/oxcarbazepine/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76506\" namespace=\"/drugs/oxcarbazepine/oral-suspension\" title=\"Oral suspension\" count=\"1\" rel=\"link\">Oral suspension</xref>\n</links>\n</topic>",
    "id": "PHP2918",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/oxcarbazepine",
    "basename": "oxcarbazepine",
    "title": "OXCARBAZEPINE",
    "interactants": [
        {
            "id": "bnf_int_900",
            "label": "Oxcarbazepine"
        }
    ],
    "vtmid": "116511002",
    "drugClassification": [
        "Antiepileptics"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Monotherapy for the treatment of focal seizures with or without secondary generalised tonic-clonic seizures",
                        "html": "Monotherapy for the treatment of focal seizures with or without secondary generalised tonic-clonic seizures"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "Initially 4&#8211;5 mg/kg twice daily (max. per dose 300 mg), then increased in steps of up to 5 mg/kg twice daily, adjusted according to response, dose to be adjusted at weekly intervals; maximum 46 mg/kg per day.",
                        "html": "<p>Initially 4&#8211;5&#8239;mg/kg twice daily (max. per dose 300&#8239;mg), then increased in steps of up to 5&#8239;mg/kg twice daily, adjusted according to response, dose to be adjusted at weekly intervals; maximum 46&#8239;mg/kg per day.</p>",
                        "ageGroup": "6&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Initially 300 mg twice daily, then increased in steps of up to 600 mg daily, adjusted according to response, dose to be adjusted at weekly intervals; usual dose 0.6&#8211;2.4 g daily in divided doses.",
                        "html": "<p>Initially 300&#8239;mg twice daily, then increased in steps of up to 600&#8239;mg daily, adjusted according to response, dose to be adjusted at weekly intervals; usual dose 0.6&#8211;2.4&#8239;g daily in divided doses.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Adjunctive therapy for the treatment of focal seizures with or without secondary generalised tonic-clonic seizures",
                        "html": "Adjunctive therapy for the treatment of focal seizures with or without secondary generalised tonic-clonic seizures"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "Initially 4&#8211;5 mg/kg twice daily (max. per dose 300 mg), then increased in steps of up to 5 mg/kg twice daily, adjusted according to response, dose to be adjusted at weekly intervals; maintenance 15 mg/kg twice daily; maximum 46 mg/kg per day.",
                        "html": "<p>Initially 4&#8211;5&#8239;mg/kg twice daily (max. per dose 300&#8239;mg), then increased in steps of up to 5&#8239;mg/kg twice daily, adjusted according to response, dose to be adjusted at weekly intervals; maintenance 15&#8239;mg/kg twice daily; maximum 46&#8239;mg/kg per day.</p>",
                        "ageGroup": "6&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Initially 300 mg twice daily, then increased in steps of up to 600 mg daily, adjusted according to response, dose to be adjusted at weekly intervals; usual dose 0.6&#8211;2.4 g daily in divided doses.",
                        "html": "<p>Initially 300&#8239;mg twice daily, then increased in steps of up to 600&#8239;mg daily, adjusted according to response, dose to be adjusted at weekly intervals; usual dose 0.6&#8211;2.4&#8239;g daily in divided doses.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Treatment of primary generalised tonic-clonic seizures",
                        "html": "Treatment of primary generalised tonic-clonic seizures"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 300 mg twice daily, then increased in steps of up to 600 mg daily, adjusted according to response, dose to be increased at weekly intervals; usual dose 0.6&#8211;2.4 g daily in divided doses.",
                        "html": "<p>Initially 300&#8239;mg twice daily, then increased in steps of up to 600&#8239;mg daily, adjusted according to response, dose to be increased at weekly intervals; usual dose 0.6&#8211;2.4&#8239;g daily in divided doses.</p>"
                    }
                ]
            }
        ],
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "title": "Dose adjustments due to interactions",
                "textContent": "In adjunctive therapy, the dose of concomitant antiepileptics may need to be reduced when using high doses of oxcarbazepine.",
                "html": "<p>In adjunctive therapy, the dose of concomitant antiepileptics may need to be reduced when using high doses of oxcarbazepine.</p>"
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "Not licensed for the treatment of primary generalised tonic-clonic seizures.",
                "html": "<p>Not licensed for the treatment of primary generalised tonic-clonic seizures.</p>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Avoid in Acute porphyrias",
                "html": "Avoid in <xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>",
                "references": [
                    {
                        "id": "PHP78608",
                        "label": "Acute porphyrias"
                    }
                ]
            },
            {
                "type": "cautions",
                "textContent": "cardiac conduction disorders",
                "html": "cardiac conduction disorders"
            },
            {
                "type": "cautions",
                "textContent": "heart failure",
                "html": "heart failure"
            },
            {
                "type": "cautions",
                "textContent": "hyponatraemia",
                "html": "hyponatraemia"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (oxcarbazepine).",
                "html": "<p>Appendix 1 (oxcarbazepine).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Abdominal pain",
                        "html": "Abdominal pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "acne",
                        "html": "acne",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "agitation",
                        "html": "agitation",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "alopecia",
                        "html": "alopecia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "amnesia",
                        "html": "amnesia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "asthenia",
                        "html": "asthenia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "ataxia",
                        "html": "ataxia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "confusion",
                        "html": "confusion",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "constipation",
                        "html": "constipation",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "depression",
                        "html": "depression",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "diplopia",
                        "html": "diplopia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "drowsiness",
                        "html": "drowsiness",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "hyponatraemia",
                        "html": "hyponatraemia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "impaired concentration",
                        "html": "impaired concentration",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nystagmus",
                        "html": "nystagmus",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "tremor",
                        "html": "tremor",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "visual disorders",
                        "html": "visual disorders",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Leucopenia",
                        "html": "Leucopenia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "urticaria",
                        "html": "urticaria",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "veryRare": [
                    {
                        "type": "veryRare",
                        "textContent": "Arrhythmias",
                        "html": "Arrhythmias",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "atrioventricular block",
                        "html": "atrioventricular block",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "hepatitis",
                        "html": "hepatitis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "multi-organ hypersensitivity disorders",
                        "html": "multi-organ hypersensitivity disorders",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "pancreatitis",
                        "html": "pancreatitis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "Stevens-Johnson syndrome",
                        "html": "Stevens-Johnson syndrome",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "systemic lupus erythematosus",
                        "html": "systemic lupus erythematosus",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "thrombocytopenia",
                        "html": "thrombocytopenia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "toxic epidermal necrolysis",
                        "html": "toxic epidermal necrolysis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Aplastic anaemia",
                        "html": "Aplastic anaemia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "bone marrow depression",
                        "html": "bone marrow depression",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypertension",
                        "html": "hypertension",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypothyroidism",
                        "html": "hypothyroidism",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "neutropenia",
                        "html": "neutropenia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "osteoporotic bone disorders",
                        "html": "osteoporotic bone disorders",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pancytopenia",
                        "html": "pancytopenia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "suicidal ideation",
                        "html": "suicidal ideation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "allergyAndCrossSensitivity": {
        "crossSensitivity": [
            {
                "type": "crossSensitivity",
                "references": [
                    {
                        "id": "PHP78230",
                        "label": "Epilepsy"
                    }
                ],
                "textContent": "Caution in patients with hypersensitivity to carbamazepine.\n\nAntiepileptic hypersensitivity syndrome associated with oxcarbazepine. See under Epilepsy for more information.",
                "html": "<p>Caution in patients with hypersensitivity to carbamazepine.</p><p>Antiepileptic hypersensitivity syndrome associated with oxcarbazepine. See under <xref format=\"dita\" href=\"#PHP78230\" type=\"bookmark\" namespace=\"/treatment-summaries/epilepsy\">Epilepsy</xref> for more information.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Amount probably too small to be harmful but manufacturer advises avoid.",
                "html": "<p>Amount probably too small to be harmful but manufacturer advises avoid.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Caution in severe impairment&#8212;no information available.",
                "html": "<p>Caution in severe impairment&#8212;no information available.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "Halve initial dose if eGFR less than 30 mL/minute/1.73 m2; increase according to response at intervals of at least 1 week.",
                "html": "<p>Halve initial dose if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>; increase according to response at intervals of at least 1 week.</p>"
            },
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Halve initial dose if estimated glomerular filtration rate less than 30 mL/minute/1.73 m2, increase according to response at intervals of at least 1 week.",
                "html": "<p>Halve initial dose if estimated glomerular filtration rate less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, increase according to response at intervals of at least 1 week.</p>"
            }
        ]
    },
    "preTreatmentScreening": {
        "preTreatmentScreening": [
            {
                "type": "preTreatmentScreening",
                "textContent": "Test for HLA-B*1502 allele in individuals of Han Chinese or Thai origin (avoid unless no alternative&#8212;risk of Stevens-Johnson syndrome in presence of HLA-B*1502 allele).",
                "html": "<p>Test for HLA-B*1502 allele in individuals of Han Chinese or Thai origin (avoid unless no alternative&#8212;risk of Stevens-Johnson syndrome in presence of HLA-B*1502 allele).</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Monitor plasma-sodium concentration in patients at risk of hyponatraemia.\n\nMonitor body-weight in patients with heart failure.",
                "html": "<p>Monitor plasma-sodium concentration in patients at risk of hyponatraemia.</p><p>Monitor body-weight in patients with heart failure.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Patients may need to be maintained on a specific manufacturer&#8217;s branded or generic oxcarbazepine product.",
                "html": "<p>Patients may need to be maintained on a specific manufacturer&#8217;s branded or generic oxcarbazepine product.</p>"
            },
            {
                "type": "prescribingAndDispensingInformation",
                "title": "Switching between formulations",
                "textContent": "Care should be taken when switching between oral formulations. The need for continued supply of a particular manufacturer's product should be based on clinical judgement and consultation with the patient or their carer, taking into account factors such as seizure frequency and treatment history.",
                "html": "<p>Care should be taken when switching between oral formulations. The need for continued supply of a particular manufacturer's product should be based on clinical judgement and consultation with the patient or their carer, taking into account factors such as seizure frequency and treatment history.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/oxcarbazepine-for-preventing-seizures",
                        "label": "www.medicinesforchildren.org.uk/oxcarbazepine-for-preventing-seizures"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children: Oxcarbazepine for preventing seizures",
                "textContent": "www.medicinesforchildren.org.uk/oxcarbazepine-for-preventing-seizures",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/oxcarbazepine-for-preventing-seizures\">www.medicinesforchildren.org.uk/oxcarbazepine-for-preventing-seizures</xref>\n</p>"
            }
        ],
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "title": "Blood, hepatic, or skin disorders",
                "textContent": "Patients or their carers should be told how to recognise signs of blood, liver, or skin disorders, and advised to seek immediate medical attention if symptoms such as lethargy, confusion, muscular twitching, fever, rash, blistering, mouth ulcers, bruising, or bleeding develop.",
                "html": "<p>Patients or their carers should be told how to recognise signs of blood, liver, or skin disorders, and advised to seek immediate medical attention if symptoms such as lethargy, confusion, muscular twitching, fever, rash, blistering, mouth ulcers, bruising, or bleeding develop.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral suspension"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76480",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76506",
                "label": "Oral suspension",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78143",
                "label": "Contraceptives, interactions",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_900",
                "label": "Oxcarbazepine",
                "type": "interaction"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78608",
                "label": "Acute porphyrias",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78230",
                "label": "Epilepsy",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76480",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76506",
                "label": "Oral suspension",
                "type": "medicinalForm"
            }
        ]
    }
}